Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.88 CAD | 0.00% | -0.17% | +2.08% |
Mar. 11 | National Bank Revises 2024, 2025 Estimates for Dexterra Group Following Q4 Results | MT |
Mar. 11 | Dexterra Upgraded to Outperform at Raymond James | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- With a P/E ratio at 11.2 for the current year and 9.43 for next year, earnings multiples are highly attractive compared with competitors.
- The stock, which is currently worth 2024 to 0.4 times its sales, is clearly overvalued in comparison with peers.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The company is one of the best yield companies with high dividend expectations.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company sustains low margins.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Hotels, Motels & Cruise Lines
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.08% | 276M | B- | ||
+4.65% | 67.64B | C+ | ||
+9.68% | 50.03B | B | ||
+15.33% | 15.31B | C+ | ||
+20.26% | 11.12B | A- | ||
+29.20% | 9.73B | A- | ||
+11.02% | 5.01B | A | ||
+9.63% | 4.6B | C- | ||
+22.47% | 3.78B | B+ | ||
+97.23% | 3.61B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- DXT Stock
- Ratings Dexterra Group Inc.